Pharmaceuticals Company Secures Patent Approval For Lead Asset For Autoimmune Diseases
Conduit Pharmaceuticals Receives Patent Approval for Lead Asset Targeting Autoimmune Diseases.
Disclaimer: This article is intended for informational purposes only and does not constitute medical advice, endorsement, or recommendations. The contents are based on publicly available information as of July 17, 2024. Readers should consult with a healthcare professional for specific medical guidance.
Real-time information is av…